Ribozyme-mediated repair of RNAs encoding mutant tumor suppressors

B A Sullenger1

  • 1Department of Experimental Surgery, Duke University Medical Center, Durham, NC, USA.

Cytokines and Molecular Therapy
|September 1, 1996
PubMed

Insights

Gene therapy offers a promising strategy for cancer treatment by restoring tumor suppressor genes. This study introduces a novel ribozyme-mediated RNA repair approach for effective gene therapy in neoplastic transformation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Genetic mutations are known to cause neoplastic transformation, leading to cancer.
  • Gene therapy is a potential cancer treatment strategy aiming to restore tumor suppressor gene expression.
  • Achieving regulated gene expression in tumor cells for therapeutic purposes remains a significant challenge.

Purpose of the Study:

  • To explore a novel gene therapy approach for cancer treatment.
  • To investigate the restoration of regulated gene expression in tumor cells.
  • To address the practical difficulties in achieving therapeutic gene expression levels.

Main Methods:

  • Developing a novel gene therapy technique.
  • Utilizing ribozymes for RNA transcript repair.
  • Applying the method to correct mutant RNA in tumor cells.

Main Results:

  • Demonstrated a novel approach for gene therapy in cancer.
  • Successfully employed ribozyme-mediated repair of mutant RNA transcripts.
  • Showcased a method to restore regulated gene expression and revert the transformed phenotype.

Conclusions:

  • Ribozyme-mediated repair of mutant RNA transcripts represents a viable novel approach to gene therapy for cancer.
  • This method offers a potential solution for achieving regulated gene expression in tumor cells.
  • Further research into this gene therapy strategy could lead to new cancer treatments.

Related Concept Videos

Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...